Literature DB >> 31119680

Chronic Nicotine Exposure Alters Metabotropic Glutamate Receptor 5: Longitudinal PET Study and Behavioural Assessment in Rats.

Adrienne Müller Herde1, Yoan Mihov2, Stefanie D Krämer1, Linjing Mu3, Antoine Adamantidis4,5, Simon M Ametamey1, Gregor Hasler6.   

Abstract

Using positron emission tomography (PET), a profound alteration of the metabotropic glutamate receptor 5 (mGluR5) was found in human smoking addiction and abstinence. As human PET data either reflect the impact of chronic nicotine exposure or a pre-existing vulnerability to nicotine addiction, we designed a preclinical, longitudinal study to investigate the effect of chronic nicotine exposure on mGluR5 with the novel radiotracer [18F]PSS232 using PET. Twelve male dark Agouti rats at the age of 6 weeks were assigned randomly to three groups. From day 0 to day 250 the groups received 0 mg/L, 4 mg/L, or 8 mg/L nicotine solution in the drinking water. From day 250 to 320 all groups received nicotine-free drinking water. PET scans with [18F]PSS232 were performed in all animals on days 0, 250, and 320. To assess locomotion, seven tests in square open field arenas were carried out 72 days after the last PET scan. During the first four tests, rats received 0 mg/L nicotine and for the last three tests 4 mg/L nicotine in the drinking water. After 250 days of nicotine consumption [18F]PSS232 binding was reduced in the striatum, hippocampus, thalamus, and midbrain. At day 320, after nicotine withdrawal, [18F]PSS232 binding increased. These effects were more pronounced in the 4 mg/L nicotine group. Chronic administration of nicotine through the drinking water reduced exploratory behaviour. This preliminary longitudinal PET study demonstrates that chronic nicotine administration alters behaviour and mGluR5 availability. Chronic nicotine administration leads to decreased [18F]PSS232 binding which normalizes after prolonged nicotine withdrawal.

Entities:  

Keywords:  Addiction; Nicotine; PET; [18F]PSS232; mGluR5

Mesh:

Substances:

Year:  2019        PMID: 31119680     DOI: 10.1007/s12640-019-00055-5

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  50 in total

1.  Nicotine behavioral sensitization in Lewis and Fischer male rats.

Authors:  Kristen R Hamilton; Amy K Starosciak; Angela Chwa; Neil E Grunberg
Journal:  Exp Clin Psychopharmacol       Date:  2012-07-09       Impact factor: 3.157

2.  Annual smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 1997-2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-07-01       Impact factor: 17.586

Review 3.  Metabotropic glutamate receptor ligands as potential therapeutics for addiction.

Authors:  M Foster Olive
Journal:  Curr Drug Abuse Rev       Date:  2009-01

4.  Random effects structure for confirmatory hypothesis testing: Keep it maximal.

Authors:  Dale J Barr; Roger Levy; Christoph Scheepers; Harry J Tily
Journal:  J Mem Lang       Date:  2013-04       Impact factor: 3.059

5.  Smoking but not cocaine use is associated with lower cerebral metabotropic glutamate receptor 5 density in humans.

Authors:  L M Hulka; V Treyer; M Scheidegger; K H Preller; M Vonmoos; M R Baumgartner; A Johayem; S M Ametamey; A Buck; E Seifritz; B B Quednow
Journal:  Mol Psychiatry       Date:  2013-04-30       Impact factor: 15.992

6.  Preclinical evaluation and test-retest studies of [(18)F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5).

Authors:  Selena Milicevic Sephton; Adrienne Müller Herde; Linjing Mu; Claudia Keller; Sonja Rüdisühli; Yves Auberson; Roger Schibli; Stefanie D Krämer; Simon M Ametamey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-20       Impact factor: 9.236

7.  Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.

Authors:  Simon M Ametamey; Lea J Kessler; Michael Honer; Matthias T Wyss; Alfred Buck; Samuel Hintermann; Yves P Auberson; Fabrizio Gasparini; Pius A Schubiger
Journal:  J Nucl Med       Date:  2006-04       Impact factor: 10.057

8.  Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688.

Authors:  Simon M Ametamey; Valerie Treyer; Johannes Streffer; Matthias T Wyss; Mark Schmidt; Milen Blagoev; Samuel Hintermann; Yves Auberson; Fabrizio Gasparini; Uta C Fischer; Alfred Buck
Journal:  J Nucl Med       Date:  2007-02       Impact factor: 10.057

9.  Effects of oral administration of nicotine on circadian rhythms of ambulatory activity and drinking in rats.

Authors:  T Kita; T Nakashima; Y Kurogochi
Journal:  Jpn J Pharmacol       Date:  1985-12

10.  Oral Nicotine Self-Administration in Rodents.

Authors:  Allan C Collins; Sakire Pogun; Tanseli Nesil; Lutfiye Kanit
Journal:  J Addict Res Ther       Date:  2012-06-01
View more
  3 in total

1.  Demographics, clinical characteristics and cognitive symptoms of heavy smokers and non-heavy smokers in Chinese male patients with chronic schizophrenia.

Authors:  Shuochi Wei; Dongmei Wang; Huixia Zhou; Luyao Xia; Yang Tian; Qilong Dai; Rongrong Zhu; Wenjia Wang; Dachun Chen; Meihong Xiu; Li Wang; Xiangyang Zhang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-04-26       Impact factor: 5.760

Review 2.  Allosteric modulation of metabotropic glutamate receptors in alcohol use disorder: Insights from preclinical investigations.

Authors:  Kari A Johnson; David M Lovinger
Journal:  Adv Pharmacol       Date:  2020-03-02

3.  Multidimensional Intersection of Nicotine, Gene Expression, and Behavior.

Authors:  Yasmine Sherafat; Malia Bautista; Christie D Fowler
Journal:  Front Behav Neurosci       Date:  2021-03-22       Impact factor: 3.558

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.